Expression of matrix metalloproteinase-9 in squamous cell carcinoma of theuterine cervix - Clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
B. Daividson et al., Expression of matrix metalloproteinase-9 in squamous cell carcinoma of theuterine cervix - Clinicopathologic study using immunohistochemistry and mRNA in situ hybridization, GYNECOL ONC, 72(3), 1999, pp. 380-386
Objective. Invasion of the extracellular matrix and blood vessels by malign
ant neoplasms, with subsequent distant dissemination, is a key event in tum
or progression. This process appears to be mediated largely through the act
ion of matrix metalloproteinases (MMPs), a family of proteolytic enzymes pr
oduced by both stromal and tumor cells. The role of gelatinases (MMP-2 and
MMP-9) in basement membrane and matrix degradation was described in various
tumors. We studied MMP-9 protein expression in cervical intraepithelial ne
oplasia (CIN) and squamous cell carcinoma using immunohistochemistry and de
tected MMP-9 mRNA using in situ hybridization.
Methods. Fifty squamous cell carcinomas, 10 cases of CIN II-III, and 10 nor
mal cervices were stained for MMP-9, using a monoclonal antibody. The prese
nce of MMP-9 mRNA was studied using in situ hybridization. Results were cor
related with patient survival during a follow-up period of up to 167 months
(average, 41 months).
Results. Immunohistochemical staining of tumor cells for MMP-9 was noted in
36/50 (72%) carcinomas and 5/10 (50%) CIN lesions, but was uniformly absen
t from the nonneoplastic epithelium adjacent to tumors and from control cer
vices. Peritumoral staining of stromal cells was observed in 27/50 (54%) ca
rcinomas, but only in 3/10 (30%) CIN lesions and 1/10 (10%) control cervice
s. The presence of MMP-9 mRNA was detected in tumor cells in 39 (78%) carci
nomas and 8 (80%) CIN lesions, but only in 4 (40%) control cervices. An int
ense signal for MMP-9 mRNA was observed most frequently in carcinomas. MMP-
9 mRNA was detected in stromal cells in the majority of cases. However, an
intense signal was observed only in stromal cells around invasive tumors. I
n survival analysis, age (P = 0.016), grade (P = 0.016), and stage (P = 0.0
01) showed independent correlation with poor survival. Neither MMP-9 protei
n expression nor an intense signal for MMP-9 mRNA was associated with poor
survival, although the latter was observed more frequently in neoplastic ce
lls of lethal tumors (8/14 tumors vs 11/36 nonlethal tumors).
Conclusions. MMP-9 mRNA and protein expression are elevated in tumor and st
romal cells of both high-grade CIN and invasive squamous cell carcinoma of
the uterine cervix. Thus, MMP-9 is possibly an early marker of tumor progre
ssion in squamous lesions of the cervix. An intense stromal signal for MMP-
9 mRNA characterizes some invasive carcinomas. Expression of MMP-9 in cervi
cal carcinoma cells is present in both lethal and nonlethal tumors, consist
ent with the key role of this proteolytic enzyme in invasion, and does not
appear to predict disease outcome. (C) 1999 Academic Press.